European Commission Approves VYNDAQEL, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Read more
Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies Read more
Novartis receives EC Approval for Beovu, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide Read more
PharmaMar and Jazz Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer Read more
Zydus Cadila launches a fast tracked programme to develop vaccine for the novel coronavirus, 2019-nCoV (COVID-19) Read more